dc.contributor.author | RTS The, S Epidemiology EPI-MAL, Study Group | |
dc.date.accessioned | 2022-01-21T11:10:32Z | |
dc.date.available | 2022-01-21T11:10:32Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/4459 | |
dc.description | https://malariajournal.biomedcentral.com/articles/10.1186/s12936-021-03670-w | en_US |
dc.description.abstract | The lack of background disease incidence rates in sub-Saharan countries where the RTS,S/AS01E
malaria vaccine is being implemented may hamper the assessment of vaccine safety and efectiveness. This study
aimed to document baseline incidence rates of meningitis, malaria, mortality, and other health outcomes prior to vaccine introduction through the Malaria Vaccine Implementation Programme | en_US |
dc.publisher | BioMed Central | en_US |
dc.subject | ubiquitination, ubiquitin proteasome system, differential gene expression, Plasmodium falciparum, malarial anemia | en_US |
dc.title | Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01E malaria vaccine | en_US |
dc.type | Article | en_US |